Core Insights - Dynatrace (DT) shares have decreased by 6.87% over the past month, underperforming both the Computer and Technology sector and the S&P 500 [1] - The upcoming earnings report on February 9, 2026, is expected to show an EPS of $0.41, a 10.81% increase year-over-year, with revenue anticipated at $505.93 million, reflecting a 15.99% rise [2] - For the full year, analysts project earnings of $1.63 per share and revenue of $1.99 billion, indicating increases of 17.27% and 17.23% respectively compared to the previous year [3] Analyst Revisions and Estimates - Recent revisions to analyst forecasts for Dynatrace are crucial as they reflect current business trends, with upward revisions indicating positive sentiment towards the company's operations [4] - The Zacks Rank system, which assesses estimate changes, currently ranks Dynatrace at 3 (Hold), with a recent 0.78% increase in the consensus EPS estimate [6] Valuation Metrics - Dynatrace is trading at a Forward P/E ratio of 25.2, which is higher than the industry average of 17.03, suggesting a premium valuation [7] - The company has a PEG ratio of 1.78, compared to the industry average of 1.42, indicating a higher expected earnings growth trajectory relative to its peers [7] Industry Context - The Computers - IT Services industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 95, placing it in the top 39% of over 250 industries [8]

Company Performance - Doximity (DOCS) closed at $38.96, down 3.56% from the previous trading session, underperforming the S&P 500's gain of 0.41% [1] - The company's shares have decreased by 8.66% over the past month, while the Medical sector lost 0.74% and the S&P 500 gained 0.38% during the same period [1] Upcoming Earnings - Doximity is set to release its earnings report on February 5, 2026, with an expected EPS of $0.44, reflecting a 2.22% decline compared to the same quarter last year [2] - Revenue is anticipated to be $181.03 million, which is a 7.37% increase from the prior-year quarter [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $1.56 per share, with revenue expected to reach $645.29 million, indicating increases of 9.86% and 13.13% respectively from the previous year [3] Analyst Estimates - Recent changes to analyst estimates for Doximity are crucial as they indicate shifts in near-term business trends, with positive revisions suggesting confidence in the company's performance [4] - The Zacks Rank system, which incorporates these estimate changes, currently ranks Doximity as 1 (Strong Buy), reflecting strong potential for outperformance [6] Valuation Metrics - Doximity has a Forward P/E ratio of 25.82, which is lower than the industry average of 27.99, indicating a valuation discount [7] - The company also has a PEG ratio of 1.36, compared to the industry average PEG ratio of 2.33, suggesting favorable growth prospects relative to its valuation [7] Industry Context - The Medical Info Systems industry, which includes Doximity, holds a Zacks Industry Rank of 82, placing it in the top 34% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1, highlighting the strength of the Medical Info Systems sector [8]

Company Performance - MPLX LP closed at $55.73, with a daily increase of +1.75%, outperforming the S&P 500's gain of 0.41% [1] - Over the past month, MPLX shares gained 1.41%, lagging behind the Oils-Energy sector's gain of 7.63% but outperforming the S&P 500's gain of 0.38% [1] Upcoming Earnings - The earnings report for MPLX LP is expected on February 3, 2026, with an anticipated EPS of $1.08, reflecting a 0.93% increase year-over-year [2] - The Zacks Consensus Estimate projects net sales of $3.34 billion, an increase of 8.88% from the previous year [2] Fiscal Year Estimates - For the entire fiscal year, the Zacks Consensus Estimates predict earnings of $4.73 per share and revenue of $13.08 billion, indicating a 12.35% increase in earnings and no change in revenue compared to the previous year [3] Analyst Estimates - Recent adjustments to analyst estimates for MPLX LP reflect short-term business trends, with upward revisions indicating analysts' positive outlook on the company's profitability [4] Zacks Rank and Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently ranks MPLX LP at 3 (Hold), with a 1.68% rise in the Zacks Consensus EPS estimate over the past month [6] Valuation Metrics - MPLX LP has a Forward P/E ratio of 12.24, which is lower than the industry average of 17.1 [7] - The company has a PEG ratio of 4.95, compared to the industry average PEG ratio of 1.81 [7] Industry Overview - The Oil and Gas - Production and Pipelines industry, part of the Oils-Energy sector, holds a Zacks Industry Rank of 99, placing it in the top 41% of over 250 industries [8]

Core Insights - Equinix (EQIX) stock closed at $806.35, reflecting a +1.91% increase from the previous day, outperforming the S&P 500's gain of 0.5% [1] - The stock has appreciated by 3.66% over the past month, contrasting with a 0.96% decline in the Finance sector and a 0.18% increase in the S&P 500 [1] Earnings Expectations - The upcoming earnings report for Equinix is scheduled for February 11, 2026, with an expected EPS of $9.08, representing a 14.65% increase year-over-year [2] - Revenue is projected to be $2.46 billion, indicating a 9% growth compared to the same quarter last year [2] Fiscal Year Projections - For the entire fiscal year, earnings are estimated at $38.49 per share, reflecting a +9.91% change from the prior year, while revenue is projected to remain stable at $9.26 billion [3] Analyst Forecast Revisions - Recent revisions to analyst forecasts for Equinix are crucial as they reflect short-term business trends, with positive revisions indicating analysts' confidence in the company's performance [4] Zacks Rank and Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently rates Equinix at 3 (Hold), with a recent EPS estimate decrease of 0.02% [6] - Historically, stocks rated 1 have delivered an average annual return of +25% since 1988 [6] Valuation Metrics - Equinix has a Forward P/E ratio of 19.51, which is a premium compared to the industry average of 13.72 [7] - The company also has a PEG ratio of 1.1, significantly lower than the industry average PEG ratio of 2.65 [7] Industry Context - The REIT and Equity Trust - Retail industry, which includes Equinix, ranks in the top 37% of all industries according to the Zacks Industry Rank [8] - The top 50% rated industries are shown to outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - Ralph Lauren's stock closed at $360.32, reflecting a -1.92% change from the previous day's closing price, which is less than the S&P 500's daily gain of 0.5% [1] - Over the past month, Ralph Lauren shares have appreciated by 2.59%, outperforming the Consumer Discretionary sector's loss of 2.73% and the S&P 500's gain of 0.18% [1] Upcoming Earnings Report - Ralph Lauren is scheduled to release its earnings on February 5, 2026, with an expected EPS of $5.55, representing a 15.15% increase from the prior-year quarter [2] - The consensus estimate for revenue is $2.31 billion, indicating a 7.77% increase compared to the year-ago quarter [2] Full Year Estimates - Analysts expect earnings of $15.42 per share and revenue of $7.78 billion for the full year, marking changes of +25.06% and +9.84% respectively from last year [3] Analyst Estimates and Outlook - Recent changes to analyst estimates for Ralph Lauren indicate a favorable outlook on the company's business health and profitability [4] - The Zacks Rank system, which includes estimate changes, currently ranks Ralph Lauren as 2 (Buy), suggesting a positive sentiment among analysts [6] Valuation Metrics - Ralph Lauren is trading at a Forward P/E ratio of 23.82, which is a premium compared to the industry average Forward P/E of 16.51 [7] - The company has a PEG ratio of 1.63, which is lower than the industry average PEG ratio of 2.8 [7] Industry Context - The Textile - Apparel industry, part of the Consumer Discretionary sector, has a Zacks Industry Rank of 63, placing it in the top 26% of all industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - Pilgrim's Pride (PPC) closed at $42.49, marking a +1.09% move from the previous day, outperforming the S&P 500 which gained 0.5% [1] - The stock has increased by 5.55% over the last month, surpassing the Consumer Staples sector's gain of 4.13% and the S&P 500's gain of 0.18% [1] Upcoming Earnings - The company is scheduled to release its earnings on February 11, 2026, with an expected EPS of $0.78, indicating a 42.22% drop compared to the same quarter of the previous year [2] Fiscal Year Estimates - Zacks Consensus Estimates project earnings of $5.32 per share and revenue of $0 million for the entire fiscal year, reflecting changes of -1.85% and 0% from the prior year [3] - Recent changes to analyst estimates indicate shifting dynamics in short-term business patterns, with positive alterations signifying analyst optimism regarding business and profitability [3] Zacks Rank and Valuation - Pilgrim's Pride currently has a Zacks Rank of 4 (Sell), with the Zacks Consensus EPS estimate moving 3.37% lower over the last 30 days [5] - The company has a Forward P/E ratio of 9.77, compared to the industry average of 12.71, suggesting it is trading at a discount [6] Industry Context - The Food - Meat Products industry, part of the Consumer Staples sector, has a Zacks Industry Rank of 98, placing it within the top 40% of over 250 industries [6] - The strength of individual industry groups is measured by the Zacks Industry Rank, with top-rated industries outperforming the bottom half by a factor of 2 to 1 [7]

Company Performance - TJX closed at $150.08, reflecting a -2.06% change from the previous day, underperforming the S&P 500's gain of 0.5% [1] - Over the last month, TJX shares decreased by 2.46%, while the Retail-Wholesale sector gained 5.24% and the S&P 500 gained 0.18% [1] Upcoming Earnings - TJX is expected to report EPS of $1.38, which is a 12.2% increase from the prior-year quarter, with anticipated revenue of $17.4 billion, indicating a 6.43% increase from the same quarter last year [2] Fiscal Year Estimates - For the entire fiscal year, earnings are projected at $4.67 per share and revenue at $60.01 billion, representing increases of +9.62% and +6.48% respectively from the prior year [3] Analyst Revisions - Recent changes to analyst estimates for TJX reflect evolving short-term business trends, with positive revisions indicating analysts' confidence in business performance and profit potential [3] Zacks Rank and Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), shows that 1 ranked stocks have yielded an average annual return of +25% since 1988; TJX currently holds a Zacks Rank of 2 (Buy) [5] Valuation Metrics - TJX has a Forward P/E ratio of 32.8, which is a premium compared to the industry average Forward P/E of 29.15; the PEG ratio stands at 3.21, aligning with the average for Retail-Discount Stores [6] Industry Ranking - The Retail-Discount Stores industry is part of the Retail-Wholesale sector and currently holds a Zacks Industry Rank of 23, placing it in the top 10% of over 250 industries [7]

Company Performance - Medpace's stock closed at $588.05, down 3.01%, underperforming the S&P 500's gain of 0.03% on the same day [1] - Over the past month, Medpace's stock has increased by 6.02%, outperforming the Medical sector's slight loss of 0.01% and the S&P 500's gain of 0.6% [1] Upcoming Earnings - Medpace is set to release its earnings report on February 9, 2026, with an expected EPS of $4.18, reflecting a 13.9% increase year-over-year [2] - Revenue is anticipated to reach $681.17 million, indicating a 26.94% rise compared to the same quarter last year [2] Annual Estimates - For the annual period, Zacks Consensus Estimates project earnings of $14.8 per share and revenue of $2.5 billion, representing increases of 17.18% and no change, respectively, from the previous year [3] - Recent revisions to analyst forecasts for Medpace are crucial as they reflect short-term business trends and can indicate analysts' positive outlook on the company's health and profitability [3] Valuation Metrics - Medpace currently has a Forward P/E ratio of 36.47, which is significantly higher than the industry average Forward P/E of 16.37 [5] - The company has a PEG ratio of 2.04, compared to the industry average PEG ratio of 1.92 [6] Industry Ranking - The Medical Services industry, which includes Medpace, has a Zacks Industry Rank of 188, placing it in the bottom 24% of over 250 industries [6] - The Zacks Industry Rank evaluates the performance of industry groups based on the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [7]

Company Performance - Toll Brothers (TOL) stock decreased by 1.79% to $144.92, underperforming the S&P 500's daily gain of 0.03% [1] - Over the past month, shares of Toll Brothers appreciated by 5.72%, which is lower than the Construction sector's gain of 6.96% but higher than the S&P 500's gain of 0.6% [1] Upcoming Earnings - Analysts expect Toll Brothers to report earnings of $2.05 per share, reflecting a year-over-year growth of 17.14% [2] - The Zacks Consensus Estimate for revenue is projected at $1.84 billion, a decrease of 0.87% from the previous year [2] Annual Forecast - For the entire year, the Zacks Consensus Estimates forecast earnings of $12.69 per share and revenue of $10.4 billion, indicating declines of 5.93% and 5.14% respectively compared to the previous year [3] Analyst Estimates - Recent changes to analyst estimates for Toll Brothers are significant as they indicate shifts in near-term business trends [4] - Upward revisions in estimates suggest analysts' positive outlook on the company's operations and profit generation capabilities [4] Stock Performance and Valuation - The Zacks Rank system, which evaluates estimate changes, currently rates Toll Brothers as 5 (Strong Sell), with a 0.63% decrease in the consensus EPS estimate over the last 30 days [6] - Toll Brothers is trading at a Forward P/E ratio of 11.63, which is lower than the industry average Forward P/E of 13.49 [7] - The company has a PEG ratio of 1.16, compared to the industry average PEG ratio of 1.8 [7] Industry Context - The Building Products - Home Builders industry, part of the Construction sector, has a Zacks Industry Rank of 242, placing it in the bottom 2% of all industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - Array Technologies, Inc. (ARRY) closed at $10.53, reflecting a -2.5% change from the previous day, which is less than the S&P 500's daily gain of 0.03% [1] - Over the past month, shares of Array Technologies gained 5.99%, lagging behind the Oils-Energy sector's gain of 6.65% but outpacing the S&P 500's gain of 0.6% [1] Upcoming Earnings - The upcoming earnings release is projected to show earnings per share (EPS) of $0, indicating a 100% decrease from the same quarter last year [2] - Revenue is estimated to be $210.84 million, reflecting a 23.4% decline compared to the corresponding quarter of the prior year [2] Full Year Estimates - For the full year, analysts expect earnings of $0.67 per share and revenue of $1.27 billion, marking changes of +11.67% and 0% respectively from last year [3] Analyst Estimates and Confidence - Recent changes to analyst estimates are important as they reflect evolving short-term business trends, with positive revisions indicating analysts' confidence in business performance [4] - The Zacks Rank system, which incorporates estimate changes, provides an actionable rating system for investors [5] Zacks Rank and Performance - Array Technologies currently holds a Zacks Rank of 1 (Strong Buy), with the Zacks Consensus EPS estimate having moved 2.29% higher within the past month [6] Valuation Metrics - Array Technologies is trading at a Forward P/E ratio of 11.17, which is a discount compared to the industry average Forward P/E of 22.54 [7] - The company's PEG ratio is currently 0.59, compared to the Solar industry's average PEG ratio of 0.69 [7] Industry Context - The Solar industry, part of the Oils-Energy sector, has a Zacks Industry Rank of 61, placing it in the top 25% of all industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]